Bank of New York Mellon Corp
BankPosition in XENE — Xenon Pharmaceuticals Inc.
CIK 1390777
NEW YORK, NY
Position in XENE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$23,035,419
+$5,683,002 QoQ
Shares Held
396,138
+2.3% QoQ
Ownership
0.410%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 86.72609040283942.ToString("F0")%
Shared 0.ToString("F0")%
None 13.273909597160586.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. XENE ranks #32 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in XENE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,035,419 | 396,138 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $17,352,417 | 387,158 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $16,799,399 | 418,416 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $13,647,420 | 436,020 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $8,425,978 | 251,147 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,826,600 | 46,597 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,924,835 | 48,891 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,998,389 | 51,254 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,880,473 | 66,910 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,070,310 | 66,659 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $5,716,639 | 167,349 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $8,152,026 | 211,741 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $7,136,058 | 199,387 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $15,313,033 | 388,360 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $15,798,983 | 437,645 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $17,132,147 | 563,187 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $17,706,386 | 579,208 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $24,727,240 | 791,525 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,281,343 | 934,643 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $17,419,791 | 935,542 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $17,150,938 | 958,153 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $8,267,108 | 746,803 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,965,398 | 794,689 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $7,664,433 | 675,876 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||